Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
Clinical trial NCT05529134 · UNKNOWN
Trial details
- NCT number
- NCT05529134
- Sponsor
- Phoenicis Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-30
- Primary completion
- 2024-04-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.